Stay updated on Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial
Sign up to get notified when there's something new on the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page.
Latest updates to the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page
- Check4 days agoChange DetectedDifference0.8%
- Check11 days agoChange DetectedThe study has posted results for a Phase 1/2 trial evaluating the safety and anti-tumor activity of galinpepimut-S in combination with pembrolizumab in patients with advanced cancers, including metastatic colorectal cancer and triple-negative breast cancer, with a focus on various treatment phases and patient response metrics.SummaryDifference69%
- Check19 days agoChange DetectedDifference0.2%
- Check26 days agoChange DetectedThe website has been updated to version v2.12.2, adding new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference2%
- Check33 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.3%
- Check41 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.6%
Stay in the know with updates to Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page.